KBI has invested in 1 company and its latest investment was Absci on Dec 04, 2019
FOLLOW STATUS
COMPANY
DESCRIPTION
AMOUNT
INVESTMENT DATE
ROUND
EXIT DATE
Absci is a Washington-based generative AI platform that offers solutions including drug discovery, screening, and synthetic biology research for the pharmaceutical sector.
